Acquisition by Dhingra Kapil of 30550 shares of Black Diamond at 4.65 subject to Rule 16b-3
| BDTX Stock | USD 2.20 0.06 2.80% |
Slightly above 56% of all Black Diamond's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Black Diamond Therapeutics suggests that some traders are interested. Black Diamond's investing sentiment can be driven by a variety of factors including economic data, Black Diamond's earnings reports, geopolitical events, and overall market trends.
Black |
Filed transaction by Black Diamond Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Black Diamond Fundamental Analysis
We analyze Black Diamond's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Black Diamond using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Black Diamond based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Black Diamond is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Black Diamond Therap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Black Diamond stock to make a market-neutral strategy. Peer analysis of Black Diamond could also be used in its relative valuation, which is a method of valuing Black Diamond by comparing valuation metrics with similar companies.
Peers
Black Diamond Related Equities
| PASG | Passage Bio | 45.61 | ||||
| ALEC | Alector | 8.99 | ||||
| ADAP | Adaptimmune Therapeutics | 4.84 | ||||
| STOK | Stoke Therapeutics | 1.95 | ||||
| RVMD | Revolution Medicines | 0.27 |
Additional Tools for Black Stock Analysis
When running Black Diamond's price analysis, check to measure Black Diamond's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Black Diamond is operating at the current time. Most of Black Diamond's value examination focuses on studying past and present price action to predict the probability of Black Diamond's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Black Diamond's price. Additionally, you may evaluate how the addition of Black Diamond to your portfolios can decrease your overall portfolio volatility.